T201-0161 Screening compound: 2-(3-methoxyphenyl)-N-[(oxolan-2-yl)methyl]-4H,5H,6H,7H,8H-pyrazolo[1,5-a][1,4]diazepine-5-carboxamide

T201-0161 Screening compound: 2-(3-methoxyphenyl)-N-[(oxolan-2-yl)methyl]-4H,5H,6H,7H,8H-pyrazolo[1,5-a][1,4]diazepine-5-carboxamide
T201-0161 Screening compound: 2-(3-methoxyphenyl)-N-[(oxolan-2-yl)methyl]-4H,5H,6H,7H,8H-pyrazolo[1,5-a][1,4]diazepine-5-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound T201-0161
2-(3-methoxyphenyl)-N-[(oxolan-2-yl)methyl]-4H,5H,6H,7H,8H-pyrazolo[1,5-a][1,4]diazepine-5-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

T201-0161

Molecular Formula

C20H26N4O3 (C20 H26 N4 O3)

Compound Name

2-(3-methoxyphenyl)-N-[(oxolan-2-yl)methyl]-4H,5H,6H,7H,8H-pyrazolo[1,5-a][1,4]diazepine-5-carboxamide

IUPAC name

2-(3-methoxyphenyl)-N-[(oxolan-2-yl)methyl]-4H5H6H7H8H-pyrazolo[15-a][14]diazepine-5-carboxamide

SMILES

COc1cccc(-c2nn(CCCN(C3)C(NCC4OCCC4)=O)c3c2)c1

InChI

InChI=1S/C20H26N4O3/c1-26-17-6-2-5-15(11-17)19-12-16-14-23(8-4-9-24(16)22-19)20(25)21-13-18-7-3-10-27-18/h2,5-6,11-12,18H,3-4,7-10,13-14H2,1H3,(H,21,25)/t18-/m1/s1

InChI Key

UKNDQPMRKJSFKQ-GOSISDBHSA-N

MDL Number (MFCD)

MFCD27618674

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

370.45

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

1.940

Distribution Coefficient, logD

1.940

Water Solubility, LogSw

-2.53

Polar Surface Area

56.758

Acid Dissociation Constant (pKa)

15.91

Base Dissociation Constant (pKb)

0.51

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

50.00

T201-0161 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Antiviral Library (67538 compounds)

Hsp90-Targeted Library (11355 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

SmartTM Library (51161 compounds)

Alpha-Helix Mimetics Library (25899 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Recognition Elements PPI Library (24135 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Immune system
Targets:
  • Kinases
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics
  • Cyclic compounds
  • Mimetics

References: we are preparing a list of scientific research reports with T201-0161 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound T201-0161?
Check Price and Availability of T201-0161, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of T201-0161 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for T201-0161
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for T201-0161
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of T201-0161 available by request